Ruiyu Wu

机构：Beijing University of Chinese Medicine · ORCID：0000-0003-3357-7925

发表论文 10 篇 · 总被引 77 次 · h-index 5

代表论文

• Salvianolic acid B protects against pulmonary fibrosis by attenuating stimulating protein 1‐mediated macrophage and alveolar type 2 cell senescence (2023 · Phytotherapy Research · 被引 30)
• Si-Wu-Tang alleviates metabolic dysfunction-associated fatty liver disease by inhibiting ACSL4-mediated arachidonic acid metabolism and ferroptosis in MCD diet-fed mice (2024 · Chinese Medicine · 被引 15)
• Tao-Hong-Si-Wu-Tang improves thioacetamide-induced liver fibrosis by reversing ACSL4-mediated lipid accumulation and promoting mitophagy (2024 · Journal of Ethnopharmacology · 被引 11)
• Safety and efficacy of aspirin after combined cerebral revascularization for ischemic moyamoya disease: A prospective study (2023 · Frontiers in Surgery · 被引 6)
• Treatment of moyamoya disease by multipoint skull drilling for indirect revascularization combined with mobilization of autologous bone marrow stem cells (2015 · Genetics and Molecular Research · 被引 6)
• Influence of Autologous Bone Marrow Stem Cell Therapy on the Levels of Inflammatory Factors and Conexin43 of Patients with Moyamoya Disease (2022 · Computational Intelligence and Neuroscience · 被引 5)